Cite
HARVARD Citation
Liang, S. et al. (2016). Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharmaceutical development and technology. pp. 121-126. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Liang, S. et al. (2016). Solution formulation development and efficacy of MJC13 in a preclinical model of castration-resistant prostate cancer. Pharmaceutical development and technology. pp. 121-126. [Online].